Prevention and Control of Noncommunicable Diseases in Armenia: The Case for Investment

This economic analysis makes the case for investing in the prevention and control of noncommunicable diseases (NCDs) in Armenia. Through three comprehensive analyses—economic burden, intervention costing, and return on investment—the report demonstrates the significant human and economic toll of NCDs, which accounted for 6.5% of Armenia’s GDP in 2017. 

Key findings: 

• 362.7 billion dram: Annual economic cost of NCDs 
• 294.9 billion dram: Indirect costs from lost productivity 
• Tobacco policy package: 14.5:1 return on investment 
• Salt reduction policy: 14.3:1 return 
• Alcohol control and physical activity awareness: 4.1–5.4:1 return 
• CVD and diabetes clinical interventions: Most expensive but essential 

The report emphasizes cost-effective WHO "Best Buy" interventions and highlights implementation gaps in current Armenian policies and services. It outlines actions needed to scale up interventions and boost returns for health and the economy.